Regarding that patent persuit, I did not recognize Revimmune (shown towards the top, together with COGNATE BIOSERVICES, INC. , NORTHWEST BIOTHERAPEUTICS , The Regents of the University of California ).
Revimmune (Trademark)... Paris, France. Owner: Linda Powers. trademark.markify.com/trademarks/ctm/revimmune/013303201
In International Class 5: Biological and pharmaceutical preparations, namely biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders. In International Class 42: Research and development of biologicals and pharmaceuticals in the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders.
OR:
Is this a different Revimmune? "Cytheris changed its name to Revimmune SAS" (01 Jul 2015) http://adisinsight.springer.com/drugs/800020133 related to Interleukin-7 such as: https://clinicaltrials.gov/ct2/show/NCT02659800 IL-7 in Increasing Low CD4 Counts After Concurrent Radiation and Temozolomide Treatment in Patients With High Grade Gliomas Sponsors and Collaborators: Sidney Kimmel Comprehensive Cancer Center National Cancer Institute (NCI) Revimmune
The patent also mentioned "Ganjel; James Kelly" Looks like he is with Toucan.
Market Data 
Markets 
AI
